
BEVVF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for BEVVF and 80,000+ other tickers.
See exactly how BEVVF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BEVVF and 80,000+ other tickers.
Bee Vectoring Technologies International Inc. (BVT) is an agricultural technology firm dedicated to developing and supplying natural, sustainable solutions for commercial farming. Their innovative product portfolio includes the "Hive and Bees" inoculum delivery system, alongside "Vectorpak with Vectorite"—a unique blend designed to enable bees to transport vital crop treatments like BVT-CR7 (an organic, naturally occurring endophytic fungus) and other beneficial microorganisms directly to plants during their foraging trips. The company also offers specialized pollen distribution systems. At…

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - February 29, 2024) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce an update on the Company's strategic partnership strategy with several multinational agriculture companies. Partnership development is BVT's core strategy for quickly scaling business and substantially broadening its addressable market.

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - February 15, 2024) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce Agrobío SL commenced trials of BVT's natural precision agriculture system in December. The trial is a part of Agrobío's participation in the EU-funded ADOPT-IPM project, which is part of the European Commission's Horizon Research and Innovations Actions (Horizon RIA), a major initiative intended to boost the EU's growth and competitiveness in areas such as tackling climate change.

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - January 31, 2024) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE)(the "Company" or "BVT") is pleased to announce that a major multi-national grower is conducting demonstration trials in Mexico with BVT's proprietary Vectorite with CR-7 (Clonostachys rosea CR-7) biological fungicide and natural precision agriculture system. "Collaborating with enterprise-sized growers with large-scale operations in multiple key growing countries is critical to BVT's overall strategy to further validate the value the BVT system brings to growers at a multi-crop and multi-national level and demonstrate its scalability potential," said Ian Collinson, Sales Manager at BVT.

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - January 16, 2024) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce South African multi-national agricultural technology business Microbial Biological Fertilizers International (MBFi) has commenced trials of BVT products in South Africa. They will be evaluating BVT's patented bee vectoring dispenser for honeybees with proprietary Vectorite powder, initially testing with MBFi's own biological strain as a comparison with traditional spray applications.

Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - December 22, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") announces that it has entered into debt settlement agreements (the "Settlement Agreement") to settle outstanding cash payments owed to certain creditors totaling $1,130,000. Pursuant to the Settlement Agreements, the Company has agreed to issue an aggregate of 18,833,334 Common shares at a deemed price of $0.06 per Common share.